ARAGONA, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 556
AS - Asia 390
EU - Europa 345
SA - Sud America 57
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.365
Nazione #
US - Stati Uniti d'America 548
SG - Singapore 173
DE - Germania 124
CN - Cina 111
IE - Irlanda 47
SE - Svezia 47
BR - Brasile 45
FI - Finlandia 42
IT - Italia 34
VN - Vietnam 29
HK - Hong Kong 28
NL - Olanda 15
ZA - Sudafrica 12
GB - Regno Unito 11
IN - India 11
TR - Turchia 8
BD - Bangladesh 7
AT - Austria 5
PL - Polonia 5
CA - Canada 4
AR - Argentina 3
BE - Belgio 3
CZ - Repubblica Ceca 3
SA - Arabia Saudita 3
BG - Bulgaria 2
EC - Ecuador 2
FR - Francia 2
IL - Israele 2
IQ - Iraq 2
IR - Iran 2
JO - Giordania 2
JP - Giappone 2
MA - Marocco 2
MX - Messico 2
MY - Malesia 2
PE - Perù 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
ES - Italia 1
EU - Europa 1
GE - Georgia 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
NP - Nepal 1
PA - Panama 1
PY - Paraguay 1
RU - Federazione Russa 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 1.365
Città #
Munich 114
Ashburn 112
Dallas 91
Singapore 82
Chandler 80
Dublin 47
Santa Clara 47
Helsinki 38
Beijing 35
Hong Kong 28
Shanghai 20
Boardman 18
Ho Chi Minh City 13
Johannesburg 12
Nanjing 12
New York 12
Los Angeles 10
Buffalo 7
Hanoi 7
Izmir 7
Princeton 7
London 6
Pune 6
São Paulo 6
Columbus 5
Parma 5
Vienna 5
Wilmington 5
Ann Arbor 4
Bremen 4
Dearborn 4
Nuremberg 4
San Mateo 4
Warsaw 4
Brussels 3
Calenzano 3
Changsha 3
Denver 3
Marnate 3
Mumbai 3
Naples 3
Ningbo 3
Norwalk 3
Shenyang 3
Tianjin 3
Amman 2
Atlanta 2
Bologna 2
Cremona 2
Da Nang 2
Dammam 2
Dhaka 2
Frankfurt am Main 2
Itabuna 2
Jyväskylä 2
Kuala Lumpur 2
Kunming 2
Lima 2
Nanchang 2
Orem 2
Phoenix 2
Rio de Janeiro 2
San Francisco 2
San Jose 2
Seattle 2
Sofia 2
Tokyo 2
Turku 2
Abidjan 1
Amsterdam 1
Américo Brasiliense 1
Andover 1
Arraial do Cabo 1
Arroio Grande 1
Baghdad 1
Bandar Seri Begawan 1
Belo Horizonte 1
Bethesda 1
Bishkek 1
Borgia 1
Boston 1
Bragança Paulista 1
Brasília 1
Buenos Aires 1
Burlington 1
Bắc Ninh 1
Campo Mara 1
Can Tho 1
Casablanca 1
Cavriago 1
Cerro Navia 1
Charleston 1
Chengdu 1
Chesterfield 1
Chicago 1
Contagem 1
Council Bluffs 1
Curitiba 1
Des Moines 1
Diyālá 1
Totale 972
Nome #
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 257
42 OP Potential use of lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: A pilot study 134
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 127
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn’s disease: Results from a large Italian cohort study 117
Clinical presentation of 324 patients with hepatocellular carcinoma (HCC) in a single center of North Italy 114
One-week H. Pylori eradication therapy Rabeprezole 20 mg bid vs 10 mg bid 93
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 87
The management of endoscopic retrograde cholangiopancreatography- related infections risk: results of an italian survey at regional level 81
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 80
Comparison of Performances of Adalimumab Biosimilars SB5, APB501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 76
Spyglass percutaneous transhepatic lithotripsy of symptomatic recurrent lithiasis of the intrahepatic bile duct with distal stenosis 71
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study 70
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 62
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study 10
Totale 1.379
Categoria #
all - tutte 5.073
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.073


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 8 5 1 1
2021/202244 1 1 0 1 4 0 5 0 4 3 5 20
2022/2023219 14 24 18 23 12 27 1 20 68 5 6 1
2023/2024118 6 10 8 5 10 19 11 23 2 6 8 10
2024/2025446 14 15 13 14 45 73 65 37 68 22 29 51
2025/2026476 80 45 119 81 121 30 0 0 0 0 0 0
Totale 1.379